[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370311-105":59,"doc-detail-370311-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lcat-in-cancer-biology-embracing-epigenetic-regulation-immune-interactions-and-therapeutic-implications","LCAT in Cancer Biology - Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications","","Lecithin cholesterol acyltransferase (LCAT) is a key HDL enzyme whose dysregulation is linked to cancer development and therapy response. The study examines LCAT expression across malignancies and connects it to clinical outcomes, including overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), using Cox regression. It integrates genomic and epigenetic features—CNVs, SNVs, DNA methylation, and m6A modifications—with immune interactions and drug sensitivity. LCAT shows cancer-dependent associations: low expression predicts poor prognosis in LGG and LIHC, whereas high expression favors ACC and COAD. The findings support LCAT as a potential biomarker and therapeutic target.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lcat-in-cancer-biology-embracing-epigenetic-regulation-immune-interactions-and-therapeutic-implications/370311/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lcat-in-cancer-biology-embracing-epigenetic-regulation-immune-interactions-and-therapeutic-implications/370311.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does LCAT play in cancer biology and HDL metabolism?","Question",{"text":113,"@type":114},"LCAT catalyzes HDL-related cholesterol processing and also influences HDL functionality. In cancer, altered LCAT activity is associated with tumor progression and therapy response through effects on metabolic and microenvironmental processes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was LCAT expression linked to patient outcomes?",{"text":118,"@type":114},"The analysis correlates LCAT expression with survival outcomes such as OS, DSS, and PFI using Cox regression across multiple cancer types.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular and epigenetic factors were evaluated for LCAT and how do they relate to immunity and treatment?",{"text":122,"@type":114},"The study evaluates CNVs, SNVs, DNA methylation, and m6A (including interactions with m6A modifiers), relating these to tumor immune responses and chemotherapeutic drug sensitivity via IC50 correlations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370311,1791105656,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nLCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications  \nManzhi Gao 1,2, Wentian Zhang 1,2, Xinxin Li 1,2, Sumin Li 1,2, Wenlan Wang 1,2, * and Peijun Han 1,2, *  \nAcademic Editor: Apostolos Zaravinos  \nReceived: 8 January 2025  \nRevised: 31 January 2025  \nAccepted: 4 February 2025  \nPublished: 10 February 2025  \nCitation: Gao, M.; Zhang, W.; Li, X.; Li, S.; Wang, W.; Han, P. LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications. Int. J. Mol. Sci. 2025, 26, 1453. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26041453](10.3390/ijms26041453)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Aerospace Hygiene, School of Aerospace Medicine, Air Force Medical University, Xi’an 710032, China; [manzhi1535675200@163.com](manzhi1535675200@163.com) (M.G.); [wentian509@163.com](wentian509@163.com) (W.Z.); [lxx1628180098@163.com](lxx1628180098@163.com) (X.L.); [lisumin15229806900@outlook.com](lisumin15229806900@outlook.com) (S.L.)  \n2 Key Laboratory of Aerospace Medicine of Ministry of Education, Air Force Medical University, Xi’an 710032, China  \n* [Correspondence: ypwl821@fmmu.edu.cn](Correspondence: ypwl821@fmmu.edu.cn) (W.W.); [peijunhan@fmmu.edu.cn](peijunhan@fmmu.edu.cn) (P.H.); Tel.: +86-13379265744 (W.W.); +86-15094070246 (P.H.)  \nAbstract: Lecithin cholesterol acyltransferase (LCAT) is a crucial enzyme in high-density lipoprotein (HDL) metabolism that is often dysregulated in cancers, affecting tumor growth and therapy response. We extensively studied LCAT expression in various malignancies, linking it to clinical outcomes and genetic/epigenetic alterations. We analyzed LCAT expression in multiple cancers and used the Cox regression model to correlate it with patient survival metrics, including overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) . We also examined the copy number variations (CNVs), single-nucleotide variations (SNVs), DNA methylation, and N6-methyladenosine (m6A) modifications of LCAT and their connections to tumor immune responses and drug sensitivity. LCAT expression varies among cancers and correlates with patient outcomes. Low expression is linked to poor prognosis in low-grade glioma (LGG) and liver hepatocellular carcinoma (LIHC), while high expression is associated with better outcomesin adrenocortical carcinoma (ACC) and colon adenocarcinoma (COAD) . In kidney renal papillary cell carcinoma (KIRP) and uterine corpus endometrial carcinoma (UCEC), LCAT CNV and methylation levels are prognostic markers. LCAT interacts with m6A modifiers and immune molecules, suggesting a role in immune evasion and as a biomarker for immunotherapy response. LCAT expression correlates with chemotherapeutic drug IC50 values, indicating potential for predicting treatment response. In ACC and COAD, LCAT may promote tumor growth, while in LGG and LIHC, it may inhibit progression. LCAT expression and activity regulation could be a new cancer therapy target. As a key molecule linking lipid metabolism, immune modulation, and tumor progression, the potential of LCAT in cancer therapy is significant. Our findings provide new insights into the role of LCAT in cancer biology and support the development of personalized treatment strategies.  \nKeywords: LCAT; HDL; cancer metabolism; immune modulation; epigenetic alterations; personalized cancer therapy  \n1. Introduction  \nLCAT facilitates the esterification of free cholesterol and its storage in the core region of HDL particles, promoting the maturation and size expansion of HDL particles. This process not only p","cbCaihUNEQfvazJ4","https://ap.wps.com/l/cbCaihUNEQfvazJ4","pdf",9868305,25,"English","# Introduction\n## LCAT and HDL in lipid metabolism\n## Rationale for studying LCAT in cancer\n## Clinical relevance and unanswered mechanisms","[{\"question\":\"What role does LCAT play in cancer biology and HDL metabolism?\",\"answer\":\"LCAT catalyzes HDL-related cholesterol processing and also influences HDL functionality. In cancer, altered LCAT activity is associated with tumor progression and therapy response through effects on metabolic and microenvironmental processes.\"},{\"question\":\"How was LCAT expression linked to patient outcomes?\",\"answer\":\"The analysis correlates LCAT expression with survival outcomes such as OS, DSS, and PFI using Cox regression across multiple cancer types.\"},{\"question\":\"Which molecular and epigenetic factors were evaluated for LCAT and how do they relate to immunity and treatment?\",\"answer\":\"The study evaluates CNVs, SNVs, DNA methylation, and m6A (including interactions with m6A modifiers), relating these to tumor immune responses and chemotherapeutic drug sensitivity via IC50 correlations.\"}]","LCAT in Cancer Biology - Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications | PDF",1790187912,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41f1c274920e935543fdf29a1e0e7cc9.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35b440ed6b544fd601e9174fa8e14a06.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5827c28a6aaec2e9b06d9c5c85cc4b7a.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d561e0fc2d1084af2805267f4f6ba1a7.webp",980,1385]